InsiderDirector

Steven Robert Pacelli Insider Trading Activity

Every SEC Form 4 transaction reported by Steven Robert Pacelli, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Steven Robert Pacelli buying or selling?

Steven Robert Pacelli reported 0 open-market buys ($0) and 72 sells ($35.1M) across 72 Form 4 filings at 1 company — a net selling position of $35.1M.

Source: SEC EDGAR Form 4

What stands out

  • All 72 of Steven Robert Pacelli's Form 4 filings are for one company, DEXCOM INC (DXCM).
  • The most recent Form 4 was accepted on Nov 27, 2023 (2 years ago).
  • No open-market purchases or sales were reported in the last 12 months.

Key Statistics (as of Nov 27, 2023)

Total Form 4 filings
72
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (72)
$35.1M

Insider sentiment

Net selling

Net insider flow of $35.1M in net selling, filed between Jul 27, 2018 – Nov 27, 2023.

Companies Steven Robert Pacelli files for

#CompanyForm 4 filings
1DXCMDEXCOM INC72

Recent Steven Robert Pacelli transactions

DateTickerRoleTypeSharesValueFiling
Nov 27, 2023DXCMEVP Managing Director Dexcom VSale411$45.5KSEC ↗
Oct 23, 2023DXCMEVP Managing Director Dexcom VSale411$35.2KSEC ↗
Sep 22, 2023DXCMEVP Managing Director Dexcom VSale411$36.3KSEC ↗
Aug 23, 2023DXCMEVP Managing Director Dexcom VSale411$44.0KSEC ↗
Jul 24, 2023DXCMEVP Managing Director Dexcom VSale412$53.8KSEC ↗
Jul 17, 2023DXCMEVP Managing Director Dexcom VSale5.0K$684.2KSEC ↗
Jun 26, 2023DXCMEVP Managing Director Dexcom VSale412$51.9KSEC ↗
May 23, 2023DXCMEVP Managing Director Dexcom VSale412$48.9KSEC ↗
Apr 27, 2023DXCMEVP Managing Director Dexcom VSale5.0K$633.9KSEC ↗
Apr 26, 2023DXCMEVP Managing Director Dexcom VSale412$51.4KSEC ↗
Mar 27, 2023DXCMEVP Managing Director Dexcom VSale5.4K$633.4KSEC ↗
Feb 23, 2023DXCMEVP Managing Director Dexcom VSale412$46.0KSEC ↗
Jan 24, 2023DXCMEVP Managing Director Dexcom VSale412$44.4KSEC ↗
Dec 27, 2022DXCMEVP Managing Director Dexcom VSale412$46.4KSEC ↗
Aug 24, 2022DXCMEVP Managing Director Dexcom VSale1.0K$84.2KSEC ↗
Jul 25, 2022DXCMEVP Managing Director Dexcom VSale1.0K$83.1KSEC ↗
Jun 27, 2022DXCMEVP Managing Director Dexcom VSale1.0K$72.5KSEC ↗
May 25, 2022DXCMEVP Managing Director Dexcom VSale250$74.1KSEC ↗
Apr 27, 2022DXCMManaging Dir., Dexcom VenturesSale250$110.0KSEC ↗
Mar 24, 2022DXCMManaging Dir., Dexcom VenturesSale250$115.0KSEC ↗
Feb 24, 2022DXCMManaging Dir., Dexcom VenturesSale250$98.6KSEC ↗
Jan 26, 2022DXCMManaging Dir., Dexcom VenturesSale250$104.2KSEC ↗
Dec 23, 2021DXCMManaging Dir., Dexcom VenturesSale250$143.5KSEC ↗
Nov 23, 2021DXCMManaging Dir., Dexcom VenturesSale250$153.1KSEC ↗
Oct 25, 2021DXCMManaging Dir., Dexcom VenturesSale250$142.5KSEC ↗

Showing the 25 most recent filings of 72. Screen every filing.

Steven Robert Pacelli insider trading FAQ

Is Steven Robert Pacelli buying or selling?

Across 72 SEC Form 4 filings, Steven Robert Pacelli reported 0 open-market purchases totaling $0 and 72 sales totaling $35.1M — a net selling position of $35.1M.

Which companies does Steven Robert Pacelli file Form 4s for?

Steven Robert Pacelli has reported insider transactions at 1 company, most often DEXCOM INC (DXCM).

How far back does Steven Robert Pacelli's filing history go?

Trabud holds Steven Robert Pacelli's SEC Form 4 filings from Jul 27, 2018 – Nov 27, 2023, sourced directly from SEC EDGAR.

Where does Trabud get Steven Robert Pacelli's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Steven Robert Pacelli and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener